The amount of F. nucleatum in human CRC tumours is inversely associated with T cell infiltration, supporting an association with reduced anti-tumour immunity [23], and F. nucleatum persistence has been linked to reduced CD8+ T cell infiltration and increased risk of recurrence following neoadjuvant chemoradiotherapy for locally advanced rectal cancer [24]. This evidence concerns the gene CD8A and neoplasm.